ExodusPoint Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-24,832
| Closed | -$677K | – | 1477 |
|
|
2023
Q3 | $677K | Sell |
24,832
-80,278
| -76% | -$2.19M | 0.01% | 1087 |
|
|
2023
Q2 | $2.34M | Buy |
105,110
+48,701
| +86% | +$1.08M | 0.02% | 668 |
|
|
2023
Q1 | $1.22M | Buy |
56,409
+14,755
| +35% | +$320K | 0.01% | 978 |
|
|
2022
Q4 | $846K | Buy |
+41,654
| New | +$846K | 0.01% | 979 |
|
|
2022
Q3 | – | Sell |
-19,210
| Closed | -$457K | – | 1891 |
|
|
2022
Q2 | $457K | Sell |
19,210
-68,544
| -78% | -$1.63M | 0.01% | 1352 |
|
|
2022
Q1 | $1.98M | Buy |
87,754
+10,727
| +14% | +$242K | 0.03% | 734 |
|
|
2021
Q4 | $1.53M | Buy |
+77,027
| New | +$1.53M | 0.02% | 835 |
|
|
2021
Q1 | – | Sell |
-16,053
| Closed | -$420K | – | 2110 |
|
|
2020
Q4 | $420K | Sell |
16,053
-27,537
| -63% | -$720K | ﹤0.01% | 1280 |
|
|
2020
Q3 | $759K | Buy |
+43,590
| New | +$759K | 0.02% | 747 |
|
|
2020
Q1 | – | Sell |
-37,139
| Closed | -$449K | – | 1109 |
|
|
2019
Q4 | $449K | Buy |
37,139
+15,074
| +68% | +$182K | 0.01% | 866 |
|
|
2019
Q3 | $312K | Buy |
+22,065
| New | +$312K | 0.01% | 827 |
|